Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Contextlogic Inc Cl A (LOGC)

Contextlogic Inc Cl A (LOGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ContextLogic Inc. Reports Third-Quarter 2024 Financial Results

LOGC : 6.97 (+1.01%)
Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics

Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company.

AZN : 64.25 (+1.66%)
LOGC : 6.97 (+1.01%)
LogicBio Therapeutics: Q3 Earnings Snapshot

LogicBio Therapeutics: Q3 Earnings Snapshot

LOGC : 6.97 (+1.01%)
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

/PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a clinical-stage genetic medicine company, today reported financial results for the third quarter...

LOGC : 6.97 (+1.01%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, JVA, AKUS, LOGC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BTRS : 9.49 (-0.11%)
JVA : 3.60 (+6.19%)
AKUS : 13.29 (+1.06%)
LOGC : 6.97 (+1.01%)
SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LOGC : 6.97 (+1.01%)
POSH : 17.90 (unch)
AERC : 3.40 (+0.59%)
BTRS : 9.49 (-0.11%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAWW, LOGC, RFP, PBFX, RNWK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AAWW : 102.48 (+0.02%)
LOGC : 6.97 (+1.01%)
RFP : 21.92 (-0.36%)
PBFX : 19.90 (-2.40%)
RNWK : 0.7300 (+0.03%)
LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of LogicBio® Therapeutics, Inc. (NasdaqGM: LOGC)...

LOGC : 6.97 (+1.01%)
SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LOGC : 6.97 (+1.01%)
POSH : 17.90 (unch)
AERC : 3.40 (+0.59%)
BTRS : 9.49 (-0.11%)
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028

Palm Beach, FL –– October 12, 2022 – FinancialNewsMedia.com News Commentary – The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth in several worldwide...

KTTA : 3.22 (+0.94%)
AZN : 64.25 (+1.66%)
LOGC : 6.97 (+1.01%)
CRDF : 2.51 (-0.79%)
SWTX : 36.28 (-3.10%)
DAWN : 13.33 (-2.13%)

Barchart Exclusives

Recent Corn Rally Artificially Propped Up – What’s Next?
Corn prices appeared to have finally found a bottom from the summer sell-off. Speculators were short the market in record numbers until late August, when they began buying back contracts, convincing some that the harvest seasonal low may be in. Then, exports increased in the last few weeks, and prices rallied more. While the bearish fundamentals of 1.9 billion carry-out and the massive amount of unpriced corn still linger, there isn’t much hope for a significant price rally yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar